IP Library Granted Patent US 7,361,335
Granted Patent B2
US 7,361,335 · App. 11/454,405 · Granted Apr 22, 2008

Methods for using an elastase

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,361,335
App. No.
11/454,405
Granted
Apr 22, 2008
Kind
B2
Abstract

The invention provides methods for treating an obstructed biological conduit that include administering to the conduit an agent that can degrade extracellular matrix of obstructing tissue. Particular methods include delivery of an enzyme or a mixture of several enzymes to the area or region of obstruction wherein the enzyme(s) have the capability to degrade extracellular matrix components within the obstruction thereby restoring the normal flow of transported fluid through the conduit. The invention also includes prophylactically dilating a section of conduit to minimize the risk of obstruction formation.

Claims (20)

1. A method of using an elastase to increase the diameter of an artery or the diameter of a vein in a human subject, the method comprising:

locally administering to the wall of the artery or the wall of the vein in the human subject a composition comprising the elastase in a dose sufficient to cause enlargement of the diameter of the artery or the diameter of the vein.

2. The method of claim 1 , wherein the composition comprises a pancreatic elastase.

3. The method of claim 1 or 2 , wherein the composition is administered by a catheter.

4. The method of claim 1 or 2 , wherein the composition is administered directly into the wall of the artery or the wall of the vein.

5. The method of claim 1 or 2 , wherein the artery or the vein is obstructed.

6. The method of claim 1 or 2 , wherein the composition is administered to an obstructed coronary artery.

7. The method of claim 1 or 2 , wherein the artery or the vein is susceptible to obstruction by intimal hyperplasia.

8. The method of claim 1 or 2 , wherein the composition does not comprise a collagenase.

9. The method of claim 1 or 2 , wherein the composition is administered to the exterior of the artery or the exterior of the vein.

10. The method of claim 1 or 2 , wherein the human subject is in need of prophylactic treatment.

11. The method of claim 1 or 2 , wherein the method further comprises inserting a portion of a delivery apparatus into the wall of the artery or the wall of the vein.

12. The method of claim 4 , wherein the artery or the vein is obstructed by intimal hyperplasia.

13. The method of claim 5 , wherein the artery or the vein is obstructed by stenosis.

14. The method of claim 13 , wherein the obstruction permits passage of an insufficient volume of blood prior to administering the composition.

15. The method of claim 14 , wherein the obstruction is a stenosis.

16. The method of claim 7 , wherein the composition is administered to the wall of a vein.

17. The method of claim 7 , wherein the vein is connected to an arteriovenous hemodialysis graft.

18. The method of claim 7 , wherein the vein is for use in hemodialysis.

19. The method of claim 18 , further comprising connecting the vein to an artery via a graft.

Assignments (8)
INVENTOR WAIVER REQUEST DECISION Recorded Jan 19, 2011
From: NATIONAL INSTITUTES OF HEALTH
To: FRANANO, F. NICHOLAS, MD
Reel/Frame 025662/0728 →
QUITCLAIM DEED Recorded Jan 19, 2011
From: FRANANO, F. NICHOLAS
To: PROTEON THERAPEUTICS, INC.
Reel/Frame 025663/0217 →
CONFIRMATORY LICENSE Recorded Dec 21, 2010
From: PROTEON THERAPEUTICS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025528/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2010
From: NATIONAL INSTITUTES OF HEALTH
To: PROTEON THERAPEUTICS INC.
Reel/Frame 025783/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2006
From: FRANANO, F. NICHOLAS
To: PROTEON THERAPEUTICS LLC
Reel/Frame 018311/0543 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2006
From: FRANANO, NICHOLAS
To: JOHNS HOPKINS UNIVERSITY
Reel/Frame 018311/0337 →
MERGER Recorded Sep 27, 2006
From: PROTEON THERAPEUTICS LLC
To: PROTEON THERAPEUTICS, INC.
Reel/Frame 018311/0428 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2006
From: JOHNS HOPKINS UNIVERSITY
To: FRANANO, F. NICHOLAS
Reel/Frame 018311/0436 →